May 19, 2006, Newsletter Issue #16: What is congress doing in response the the Vioxx affair?
Tip of the Week
The House Committee on Government Reformheld a hearing in Washington on May 5, 2005 on what Merck, the third-largest U.S. drugmaker, and the U.S. Food and Drug Administration should have done to protect the public from the dangers of Vioxx. The committee said its staff examined more than 20,000 pages of Vioxx-related documents before the meeting. Representative Gil Gutknecht, a Minnesota Republican, told the committee "It (the FDA) seems to be that they are shirking their responsibility to consumers and physicians."
About LifeTips
Now one of the top on-line publishers in the world, LifeTips offers tips to millions of monthly visitors. Our mission mission is to make your life smarter, better, faster and wiser. Expert writers earn dough for what they know. And exclusive sponsors in each niche topic help us make-it-all happen.
